1. Home
  2. ADUS vs OGN Comparison

ADUS vs OGN Comparison

Compare ADUS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$104.64

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.54

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
OGN
Founded
1979
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
ADUS
OGN
Price
$104.64
$13.54
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$133.78
$11.40
AVG Volume (30 Days)
226.0K
2.3M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
23.40
N/A
EPS
1.36
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$9.17
$0.45
Revenue Next Year
$4.70
$1.67
P/E Ratio
$77.33
$24.64
Revenue Growth
N/A
N/A
52 Week Low
$87.95
$5.69
52 Week High
$124.44
$13.60

Technical Indicators

Market Signals
Indicator
ADUS
OGN
Relative Strength Index (RSI) 77.90 72.77
Support Level $101.29 $10.05
Resistance Level $112.98 N/A
Average True Range (ATR) 2.61 0.06
MACD 1.13 -0.05
Stochastic Oscillator 96.04 76.19

Price Performance

Historical Comparison
ADUS
OGN

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: